TipHub

₹61.9

▲ +1.53 +2.53%

29 Jul 2026

NSE Listed · Pharmaceuticals

Valiant Laboratories Ltd. (VALIANTLAB)

Volume: 20,864Avg Vol 1W: 9,667Avg Vol 1M: 10,48752W Range:₹49.51₹100.98
NSE BSE www.valiantlabs.in AI Report
Key Ratios
Checked just now
Market Cap₹336 Cr
Current Price₹61.9
Previous Close₹60.37
High / Low (52w)₹100.98 / ₹49.51
Volume20,864
Avg Vol (1W)9,667
Avg Vol (1M)10,487
Stock P/E188.66
Book Value₹57.24
Dividend Yield0%
ROE-105.12%
ROA-70.69%
Revenue (TTM)—
Revenue Growth-26.74%
Profit Margin-138.13%
Total Debt₹104 Cr
Shares Outstanding5 Cr
Face Value₹10
EPS (TTM)₹0
P/B1.08
Debt / Equity0.42
50 DMA₹68.31
200 DMA₹68.41
Day change+2.53%
Price Chart
₹61.9▼ 29.74% · 1Y
₹102₹519.1L
2025-07-29
2026-07-29

20-day avg volume: 10K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 19% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 189.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹19 Cr₹21 Cr₹35 Cr₹58 Cr₹47 Cr₹46 Cr₹52 Cr₹92 Cr
EBITDA₹0 Cr₹-4 Cr₹2 Cr₹1 Cr₹3 Cr₹0 Cr₹-2 Cr₹2 Cr
Net Profit₹-1 Cr₹-5 Cr₹2 Cr₹1 Cr₹2 Cr₹0 Cr₹-7 Cr₹2 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹21 Cr₹35 Cr₹58 Cr₹139 Cr₹51 Cr₹46 Cr₹55 Cr₹65 Cr
EBITDA₹-5 Cr₹1 Cr₹4 Cr₹-1 Cr₹3 Cr₹0 Cr₹0 Cr₹5 Cr
Net Profit₹-6 Cr₹2 Cr₹3 Cr₹-2 Cr₹2 Cr₹0 Cr₹0 Cr₹4 Cr
EPS———-0.51————
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹106 Cr₹182 Cr₹213 Cr₹343 Cr₹401 Cr
Total Liabilities₹18 Cr₹110 Cr₹112 Cr₹106 Cr₹167 Cr
Equity₹89 Cr₹71 Cr₹100 Cr₹237 Cr₹234 Cr
Total Debt₹0 Cr₹59 Cr———
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹26 Cr₹17 Cr₹65 Cr₹1 Cr₹-1 Cr
Investing₹-17 Cr₹-12 Cr₹-55 Cr₹-144 Cr₹-53 Cr
Financing₹11 Cr₹6 Cr₹-1 Cr₹152 Cr₹45 Cr
Free Cash Flow₹26 Cr₹17 Cr₹65 Cr₹1 Cr₹-1 Cr
Shareholding
Promoter 74.94% Institutions 0% Public 25.06%
Efficiency & Working Capital
ROCE0.7%
Interest Coverage-17.7
Dividend Payout—
Debtor Days197 d
Inventory Days11 d
Payable Days111 d
Cash Conversion Cycle97 d
Working Capital Days208 d
Shareholding Details

As of 2026-06-30

Promoter74.9%
FII0%
DII0%
Institutions0%
Public25.1%
Promoter Pledge0%
No. of Shareholders14,341
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Aug 2025Aug 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%74.9%
FIIs3.5%1.9%0%0%0.6%0.6%0.5%0.5%0%0%0.2%0%
DIIs0%0%0%0%0%0.5%0%0%0%0%0%0%
Public21.5%23.2%25.1%25.1%24.4%24%24.5%24.5%25%25.1%24.9%25.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders14,91414,24915,18915,69215,03614,43214,94814,94815,07514,91014,65714,341
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Dhanvallabh Ventures LlpShareholding of Promoter and Promoter Group46.8%2.54 Cr
Paresh Shashikant ShahShareholding of Promoter and Promoter Group9.4%50,84,612
Santosh Shantilal VoraShareholding of Promoter and Promoter Group7.5%40,73,987
Shanilal Shivji VoraShareholding of Promoter and Promoter Group7.5%40,73,987
Kanchan Shantilal VoraShareholding of Promoter and Promoter Group3.7%20,18,362
Anil Vishanji DedhiaPublic Shareholding1.8%10,00,000
Rachi Santosh VoraShareholding of Promoter and Promoter Group0%8,662
Varsha Paresh ShahShareholding of Promoter and Promoter Group0%2,887
Sangita Manoj JainShareholding of Promoter and Promoter Group0%1,490
Board of Directors
NameDesignationYear
Mulesh Manilal SavlaChairman & Independent Directo2025
Santosh S. VoraED / MD / Promoter2025
Paresh Shashikant ShahED / WTD / CFO / Promoter2025
Shantilal Shivji VoraNon Executive Director2025
Sandeep GuptaNon Executive Director2025
Sona! A. ViraIndependent Non Exe. Director2025
Ashok Lakhamshi ChhedaIndependent Non Exe. Director2025
Akshay GangurdeCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
Within India₹133 Cr99.5%
Outside India₹1 Cr0.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10604343
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202525300815378
20252530071314
20250000353
Company Information
Incorporated2021
ChairmanMulesh Manilal Savla
AuditorRaman S Shah & Co
Investor Email[email protected]
🌐 www.valiantlabs.in ↗

📍 104 Udyog Kshetra Mulund, Goregaon Link Rd Mulund West, Mumbai, Maharashtra, 400080

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

U. Y. Fincorp LimitedV2 Retail LimitedVadilal Industries Ltd.Vaibhav Global LimitedVaishali Pharma LimitedVakrangee LimitedValiant Organics LimitedValue 360 Communication LimitedVedanta Aluminium Metal LimitedVardhaman Acrylics Ltd.Vardhman Polytex Ltd.Varroc Engineering Ltd.All “V” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search